The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations

Published:2013-03-05 Issue:3 Volume:32 Page:136-140
ISSN:1000-467X
Container-title:Chinese Journal of Cancer
language:
Short-container-title:Chin J Cancer

Author:

Suzuki Hidekazu,Hirashima Tomonori,Okamoto Norio,Yamadori Tadahiro,Tamiya Motohiro,Morishita Naoko,Shiroyama Takayuki,Otsuka Tomoyuki,Kitai Kanako,Kawase Ichiro

Publisher

Editorial Office of Chinese Journal of Cancer

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Looking into the toxicity potential and clinical benefits of tyrosine kinase inhibitors (TKIs);Reference Module in Biomedical Sciences;2022

2. SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling;Frontiers in Oncology;2021-02-11

3. Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation;Nature Cell Biology;2015-08-17

4. Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement;Chinese Journal of Cancer;2015-08-08

5. Parallel phase 1 clinical trials in the US and in China: accelerating the test of avitinib in lung cancer as a novel inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance;Chinese Journal of Cancer;2015-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP